Novavax expands deal with Serum Institute, aims for two billion COVID-19 vaccine doses
Serum Institute will also manufacture the antigen component of the vaccine, dubbed NVX‑CoV2373
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.